Sampo

Sampo’s Q3 report was excellent in terms of numbers, but operationally, it did not contain any major surprises. Changes to our estimates have remained marginal, and we still expect the company to achieve strong annual earnings growth of around 10% in the coming years. However, we believe the share is fairly valued and thus reiterate our Reduce recommendation and our EUR 10.0 target price.

Today, we hosted a live online event with Sampo’s Head of Investor Relations, Sami Taipalus, who presented the results for the third quarter and the first nine months of 2025. He also discussed the raised 2024–2026 financial targets and shared insights on the outlook for the remainder of 2025. The presentation was followed by a Q&A session.

11:41

Sampo’s tone has turned more growth-oriented under its new CEO. CFO Knut Arne Alsaker elaborates on the company’s thinking in an interview with inderesTV.

A Northern European P&C insurance group, Sampo will publish its Q3 Financial Report for 2025 on November 5, 2025. Later the same day, we will host a live online event with Sampo’s Head of Investor Relations, Sami Taipalus, at 13:30 CET. The event will include a brief presentation of the results and Sampo’s outlook for 2025. The presentation will be followed by a Q&A session.

Sampo Group continued its solid financial performance in January-September 2025, driven by positive momentum across private and SME lines, and strong underwriting performance in a favourable claims environment.

Dagens aktienyheder med ISS, Sampo, Ascelia Pharma, Bioporto, og Scandinavian Medical Solutions

Video review on Q3/2025 results - 5 November 2025.

Mød ledelsen i ISS og Sampo og stil spørgsmål til dagens investorpræsentationer